With green light from European Commission, Novo Holdings' proposed $16.5B Catalent buyout nears close

With green light from European Commission, Novo Holdings' proposed $16.5B Catalent buyout nears close

Source: 
Fierce Pharma
snippet: 

As the clock ticks down on 2024, Novo Holdings’ proposed $16.5 billion buyout of CDMO giant Catalent—which the companies have said they expect to close before year-end—just received a major vote of confidence from antitrust officials overseas.